{
    "id": 10186,
    "fullName": "DDIT4 wild-type",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "Wild-type DDIT4 indicates that no mutation has been detected within the DDIT4 gene.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 54541,
        "geneSymbol": "DDIT4",
        "terms": [
            "DDIT4",
            "Dig2",
            "REDD-1",
            "REDD1"
        ]
    },
    "variant": "wild-type",
    "createDate": "08/05/2015",
    "updateDate": "07/11/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 2690,
            "approvalStatus": "Preclinical",
            "evidenceType": "Emerging",
            "efficacyEvidence": "DDIT4 inhibits mTOR, and compounds that increase DDIT4 expression have been demonstrated to decrease mTOR signaling and tumor cell growth, suggesting that DDIT4 is a potential therapeutic target in cancers with aberrant mTOR activation (PMID: 24713927, PMID: 25151963, PMID: 24515947, PMID: 25543165).",
            "molecularProfile": {
                "id": 10189,
                "profileName": "DDIT4 wild-type"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 3403,
                    "pubMedId": 24713927,
                    "title": "MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24713927"
                },
                {
                    "id": 3404,
                    "pubMedId": 25151963,
                    "title": "Fatty acid synthase inhibition engages a novel caspase-2 regulatory mechanism to induce ovarian cancer cell death.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25151963"
                },
                {
                    "id": 3405,
                    "pubMedId": 24515947,
                    "title": "Methylseleninic acid elevates REDD1 and inhibits prostate cancer cell growth despite AKT activation and mTOR dysregulation in hypoxia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24515947"
                },
                {
                    "id": 3406,
                    "pubMedId": 25543165,
                    "title": "Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25543165"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 10189,
            "profileName": "DDIT4 wild-type",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}